Table 5 Comparison of IM versus non-IM in all samples adjusted for the same patients.

From: Long-term effects of H. pylori eradication on epigenetic alterations related to gastric carcinogenesis

Variable

IM vs non-IM

Odds ratio

95% confidence interval

P

MSI

5.90

1.63–21.35

0.007

CIMP

4.45

1.44–13.78

0.001

CDH1

0.16

0.06–0.42

0.0002

CDKN2A

0.25

0.02–2.76

0.26

MLH1

MGMT

MINT1

13.74

4.84–39.06

<0.0001

MINT31

5.96

2.55–13.93

<0.0001

RUNX3

22.92

3.02–173.75

0.002

miR-124a-3

miR-34c

43.69

5.91–322.84

0.0002

  1. IM, intestinal metaplasia.